FI20105991A0 - Adenovirusvektoreita ja menetelmiä ja käyttöjä niihin liittyen - Google Patents

Adenovirusvektoreita ja menetelmiä ja käyttöjä niihin liittyen

Info

Publication number
FI20105991A0
FI20105991A0 FI20105991A FI20105991A FI20105991A0 FI 20105991 A0 FI20105991 A0 FI 20105991A0 FI 20105991 A FI20105991 A FI 20105991A FI 20105991 A FI20105991 A FI 20105991A FI 20105991 A0 FI20105991 A0 FI 20105991A0
Authority
FI
Finland
Prior art keywords
methods
adenovirus vectors
uses therefor
therefor
adenovirus
Prior art date
Application number
FI20105991A
Other languages
English (en)
Swedish (sv)
Other versions
FI124927B (fi
FI20105991A (fi
Inventor
Joao Dias
Cerullo Vincenzo
Akseli Hemminki
Sari Pesonen
Original Assignee
Oncos Therapeutics Oy
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Oncos Therapeutics Oy filed Critical Oncos Therapeutics Oy
Publication of FI20105991A0 publication Critical patent/FI20105991A0/fi
Priority to FI20105991A priority Critical patent/FI124927B/fi
Priority to US13/825,852 priority patent/US20130243731A1/en
Priority to SG2013019120A priority patent/SG189001A1/en
Priority to AU2011306845A priority patent/AU2011306845C1/en
Priority to KR1020137010377A priority patent/KR20130108371A/ko
Priority to PCT/FI2011/050822 priority patent/WO2012038606A1/en
Priority to CA2812093A priority patent/CA2812093A1/en
Priority to RU2013118723/10A priority patent/RU2013118723A/ru
Priority to EP11770846.1A priority patent/EP2619312A1/en
Priority to CN2011800533195A priority patent/CN103221544A/zh
Priority to BR112013006699A priority patent/BR112013006699A2/pt
Priority to JP2013529691A priority patent/JP2014500004A/ja
Publication of FI20105991A publication Critical patent/FI20105991A/fi
Priority to ZA2013/02429A priority patent/ZA201302429B/en
Application granted granted Critical
Publication of FI124927B publication Critical patent/FI124927B/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86—Viral vectors
    • C12N15/861—Adenoviral vectors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • A61K48/005—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy characterised by an aspect of the 'active' part of the composition delivered, i.e. the nucleic acid delivered
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/10—Cells modified by introduction of foreign genetic material

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Cell Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Virology (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Plant Pathology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
FI20105991A 2010-09-24 2010-09-24 Adenovirusvektoreita ja niihin liittyviä menetelmiä ja käyttöjä FI124927B (fi)

Priority Applications (13)

Application Number Priority Date Filing Date Title
FI20105991A FI124927B (fi) 2010-09-24 2010-09-24 Adenovirusvektoreita ja niihin liittyviä menetelmiä ja käyttöjä
CA2812093A CA2812093A1 (en) 2010-09-24 2011-09-23 Oncolytic adenoviral vectors coding for monoclonal anti - ctla - 4 antibodies
EP11770846.1A EP2619312A1 (en) 2010-09-24 2011-09-23 Oncolytic adenoviral vectors coding for monoclonal anti - ctla - 4 antibodies
AU2011306845A AU2011306845C1 (en) 2010-09-24 2011-09-23 Oncolytic adenoviral vectors coding for monoclonal anti - CTLA - 4 antibodies
KR1020137010377A KR20130108371A (ko) 2010-09-24 2011-09-23 단클론 항―ｃｔｌａ－４ 항체를 암호화하는 종양분해 아데노바이러스 벡터
PCT/FI2011/050822 WO2012038606A1 (en) 2010-09-24 2011-09-23 Oncolytic adenoviral vectors coding for monoclonal anti - ctla - 4 antibodies
US13/825,852 US20130243731A1 (en) 2010-09-24 2011-09-23 Oncolytic adenoviral vectors coding for monoclonal anti-ctla-4 antibodies
RU2013118723/10A RU2013118723A (ru) 2010-09-24 2011-09-23 Онколитические аденовирусные векторы, кодирующие моноклональные антитела против ctla-4
SG2013019120A SG189001A1 (en) 2010-09-24 2011-09-23 Oncolytic adenoviral vectors coding for monoclonal anti - ctla - 4 antibodies
CN2011800533195A CN103221544A (zh) 2010-09-24 2011-09-23 编码单克隆抗-ctla-4抗体的溶瘤腺病毒载体
BR112013006699A BR112013006699A2 (pt) 2010-09-24 2011-09-23 vetor adenoviral oncolítico que codifica anticorpos anti-ctl4-4 monoclonais, célula e composição farmacêutica compreendendo o mesmo, método de produção de anticorpo monoclonal humano específico para ctla-4 em uma célula e uso do referido vetor adenoviral
JP2013529691A JP2014500004A (ja) 2010-09-24 2011-09-23 抗ｃｔｌａ−４モノクローナル抗体をコードする腫瘍溶解性アデノウイルスベクター
ZA2013/02429A ZA201302429B (en) 2010-09-24 2013-04-04 Oncolytic adenoviral vectors coding for monoclonal anti-ctla-4 antibodies

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FI20105991 2010-09-24
FI20105991A FI124927B (fi) 2010-09-24 2010-09-24 Adenovirusvektoreita ja niihin liittyviä menetelmiä ja käyttöjä

Publications (3)

Publication Number Publication Date
FI20105991A0 true FI20105991A0 (fi) 2010-09-24
FI20105991A FI20105991A (fi) 2012-03-25
FI124927B FI124927B (fi) 2015-03-31

Family

ID=42829720

Family Applications (1)

Application Number Title Priority Date Filing Date
FI20105991A FI124927B (fi) 2010-09-24 2010-09-24 Adenovirusvektoreita ja niihin liittyviä menetelmiä ja käyttöjä

Country Status (1)

Country Link
FI (1) FI124927B (fi)

Also Published As

Publication number Publication date
FI124927B (fi) 2015-03-31
FI20105991A (fi) 2012-03-25

Similar Documents

Publication Publication Date Title
FR21C1026I1 (fr) Adenovirus simien et vecteurs adenoviraux hybrides
SMT201500291B (it) Nuovi agenti antimalarici
FI20100223A0 (fi) Menetelmä ja hissijärjestely
BR112012017441A2 (pt) compostos e métodos
DK3457689T3 (da) Ny planar forudsigelsestilstand
FI20106273A (fi) Hissijärjestely ja menetelmä
DK3053932T3 (da) Hidtil ukendte ctla4-ig-immunoadhesiner
FI20105572A0 (fi) Muokattu beeta-laktamaasi ja siihen liittyvät menetelmät ja käytöt
DK2567097T3 (da) Centrifugalpumpe
DE112011102851A5 (de) Drehsteller
FI20095751A (fi) Ei Ad5 adenoviraaliset vektorit ja niihin liittyvät menetelmät ja käytöt
FI20105941A (fi) Kipsausmateriaalit
BR112012025091A2 (pt) caixa
DK2571902T3 (da) Ny fremgangsmåde
BR112012025094A2 (pt) caixa
FI20115631A0 (fi) Immunostimulatoriset yhdisteet ja niiden käyttö
DE112011104138A5 (de) Mobile Inversionstrommel
IT1401836B1 (it) Tesa portaocchiali
FR2958525B1 (fr) Eponge
ES1071902Y (es) Mecanismo de termosoldadura y precorte
BR112013013441A2 (pt) composição de adesivo-engomadura e métodos relacionados
FR2957892B3 (fr) Trottinette amelioree
FI20105278A0 (fi) Uusi laite
FI20105991A0 (fi) Adenovirusvektoreita ja menetelmiä ja käyttöjä niihin liittyen
FI20105954A0 (fi) Asennuskehikko ja menetelmä

Legal Events

Date Code Title Description
FG Patent granted

Ref document number: 124927

Country of ref document: FI

Kind code of ref document: B

MM Patent lapsed